Know-Legal Web Search

Search results

1. Results From The WOW.Com Content Network

2. TracFone Wireless - Wikipedia

   en.wikipedia.org/wiki/TracFone_Wireless

   TracFone Wireless, Inc. (TFWI) is an American wireless prepaid service provider.It is a mobile virtual network operator offering prepaid and no-contract services on the Verizon network under multiple brands, including TracFone, Straight Talk Wireless, Total Wireless, Simple Mobile, SafeLink Wireless, Page Plus Cellular, Net10 Wireless, GoSmart Mobile, and Walmart Family Mobile (in partnership ...

3. AOL Mail

   mail.aol.com

   Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

4. List of mobile virtual network operators in the United States ...

   en.wikipedia.org/wiki/List_of_mobile_virtual...

   Mobile virtual network operators (MVNOs) in the United States lease wireless telephone and data service from the four major cellular carriers in the country—AT&T Mobility, Boost Mobile, T-Mobile US, and Verizon—and offer various levels of free and/or paid talk, text and data services to their customers.

5. There are early Prime Day Apple deals that can't be ignored ...

   www.aol.com/lifestyle/there-are-early-prime-day...

   Apple deals are not something we can generally shout from the rooftops, but as of late, there have been jaw-dropping deals on some top sellers, like AirTags for $25, over 30% off AirPods, and over ...

6. Verizon - Wikipedia

   en.wikipedia.org/wiki/Verizon

   Verizon Communications Inc. (/ v ə ˈ r aɪ z ən / və-RY-zən), is an American telecommunications company headquartered in New York City. [3] It is the world's second-largest telecommunications company (after China Mobile) by revenue and its mobile network is the largest wireless carrier in the United States, with 114.8 million subscribers as of March 31, 2024.

7. Pfizer withdraws sickle cell disease treatment on risk of ...

   www.aol.com/news/pfizer-withdraws-sickle-cell...

   Pfizer bought Oxbryta, also known as voxelotor, as part of its $5.4 billion buyout of Global Blood Therapeutics in 2022. Pfizer is also discontinuing all studies and access programs related to the ...